Live feed
Filing
SC 13G/A
SC 13G/A0001193125-17-112092·Ally Bridge Group Capital Partners II, L.P.
Schedule 13G ownership disclosure
DIFFUSION PHARMACEUTICALS IN
Security class unavailable · CUSIP: 253748206
Event date: 2017-03-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-17-112092
- Form type
- SC 13G/A
- Filer
- Ally Bridge Group Capital Partners II, L.P.
- CIK
- CIK 1609313
- Filed
- Apr 06, 2017
- Reporting period
- Mar 31, 2017
- Description
- Schedule 13G beneficial ownership